192 related articles for article (PubMed ID: 16189130)
1. Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.
Webber MA; Talukder A; Piddock LJ
Antimicrob Agents Chemother; 2005 Oct; 49(10):4390-2. PubMed ID: 16189130
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets.
Costa D; Poeta P; Sáenz Y; Coelho AC; Matos M; Vinué L; Rodrigues J; Torres C
Vet Microbiol; 2008 Feb; 127(1-2):97-105. PubMed ID: 17870255
[TBL] [Abstract][Full Text] [Related]
3. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli.
Webber MA; Piddock LJ
Antimicrob Agents Chemother; 2001 May; 45(5):1550-2. PubMed ID: 11302826
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].
Coban AY; Birinci A; Ekinci B; Durupinar B
Mikrobiyol Bul; 2004; 38(1-2):21-5. PubMed ID: 15293898
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
6. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
[No Abstract] [Full Text] [Related]
7. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
[TBL] [Abstract][Full Text] [Related]
8. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase.
Poirel L; Pitout JD; Calvo L; Rodriguez-Martinez JM; Church D; Nordmann P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1525-7. PubMed ID: 16569874
[TBL] [Abstract][Full Text] [Related]
9. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
[TBL] [Abstract][Full Text] [Related]
10. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
11. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea.
Mendez Arancibia E; Pitart C; Ruiz J; Marco F; Gascón J; Vila J
J Antimicrob Chemother; 2009 Aug; 64(2):343-7. PubMed ID: 19474067
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
13. Identification of plasmid-mediated quinolone resistance qnr-like genes in Romanian clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Usein CR; Palade AM; Tatu-Chiţoiu D; Ciontea S; Ceciu S; Nica M; Damian M
Roum Arch Microbiol Immunol; 2009; 68(1):55-7. PubMed ID: 19507629
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli at a general hospital].
Serrano FJ; Muñoz RM; Vidal SS; Morán FG; García CB; Aznar AB
Rev Esp Quimioter; 2000 Mar; 13(1):44-50. PubMed ID: 10855024
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
16. A novel alanine to serine substitution mutation in SoxS induces overexpression of efflux pumps and contributes to multidrug resistance in clinical Escherichia coli isolates.
Aly SA; Boothe DM; Suh SJ
J Antimicrob Chemother; 2015 Aug; 70(8):2228-33. PubMed ID: 25921515
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
Chenia HY; Pillay B; Pillay D
J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
[TBL] [Abstract][Full Text] [Related]
18. Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples.
Gagliotti C; Nobilio L; Moro ML;
Clin Microbiol Infect; 2007 Mar; 13(3):328-31. PubMed ID: 17391392
[TBL] [Abstract][Full Text] [Related]
19. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
[TBL] [Abstract][Full Text] [Related]
20. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
